Trump trade threats compound global ocean shipping uncertainty
By Lisa Baertlein LONG BEACH, California (Reuters) – The global ocean shipping industry that handles 80% of world trade is navigating a sea of unknowns
Traders place record bet on rising Japanese yen, eyeing further rate hikes
By Harry Robertson LONDON (Reuters) – Speculators have mounted their biggest ever wager that the Japanese yen will continue to rise as they position for
Exclusive-Nvidia and Broadcom testing chips on Intel manufacturing process, sources say
By Max A. Cherney and Fanny Potkin SAN FRANCISCO/SINGAPORE (Reuters) – Chip designers Nvidia and Broadcom are running manufacturing tests with Intel, two sources familiar
CME Group plans to launch Solana futures on March 17
By Suzanne McGee (Reuters) – CME Group said on Friday that it plans to roll out futures contracts on cryptocurrency Solana on March 17, pending
Skype’s final call set for May as Microsoft prioritizes Teams
(Reuters) – Skype will ring for the last time on May 5 as owner Microsoft retires the two-decade-old internet calling service that redefined how people
GM’s electric gains face critical test as Trump targets EV subsidies
By Kalea Hall DETROIT (Reuters) – General Motors has spent billions over decades trying to blaze an electric trail, releasing pioneering EVs and hybrids that
China accuses US of fentanyl ‘blackmail’ after latest tariff threat
By Joe Cash and Laurie Chen BEIJING (Reuters) – Beijing accused the United States on Friday of exerting “tariff pressure and blackmail” after President Donald
Elon Musk throws weight behind merging FTC and DOJ antitrust units
By Jody Godoy (Reuters) – Elon Musk, the billionaire behind President Donald Trump’s efforts to shrink the U.S. government, threw his support behind a bill
Apple sued over ‘carbon neutral’ claim for watches
By Jonathan Stempel (Reuters) – Apple has been sued by consumers who said its claim that three versions of Apple Watches are “carbon neutral” and
Flu vaccine panel meeting canceled, US FDA confirms
(Reuters) -The U.S. Food and Drug Administration confirmed on Thursday that a meeting of its independent advisory panel to discuss the composition of this year’s